While drugmakers Novo Nordisk and Eli Lilly assert that shortages of popular weight loss and diabetes medications Wegovy, Ozempic, Mounjaro and Zepbound are easing, many patients continue to face challenges accessing the drugs, NPR reported Sept. 6.
Leqembi, an Alzheimer's drug from Biogen and Eisai, faces hurdles with respect to reimbursement and diagnostic uncertainties, diagnostic test requirements and the need for regular brain scans, CNBC reported Sept. 8.
A federal judge in Baltimore has denied a request by major drug companies to block a new Maryland law that requires them to sell discounts on medications sold through third-party pharmacies affiliated with hospitals and clinics serving low-income populations, Reuter's…
Existing arthritis drugs could help stop lingering lung problems that can last up to years after COVID-19 infections, according to a study from researchers at Charlottesville, Va.-based UVA Health and Los Angeles-based Cedars-Sinai.
A new study by researchers at Salt Lake City-based University of Utah School of Medicine set out to highlight the environmental costs that come with unnecessary antibiotic prescriptions in outpatient settings.
After Kentucky pharmacy workers dispensed compounded medications to three children, they were all hospitalized. The Kentucky Board of Pharmacy is investigating the situation.
The American Hospital Association, 340B Health and the American Society of Health-System Pharmacists filed a motion asking for permission to submit an amicus brief to support the defendants in a lawsuit brought by Novartis Pharmaceuticals.
As major pharmacy chains start rolling out the new COVID-19 vaccine, independent pharmacies report facing shipment delays, resulting in longer wait times for patient vaccinations, NBC News reported Sept. 5.
